Photobiomodulation therapy inhibits oral submucous fibrosis in mice
- PMID: 32391600
- PMCID: PMC7540580
- DOI: 10.1111/odi.13409
Photobiomodulation therapy inhibits oral submucous fibrosis in mice
Abstract
Objectives: Oral submucous fibrosis (OSMF) is a chronic inflammatory disease and a potentially malignant oral disorder. However, the best therapeutic treatment for OSMF remains uncertain. Our previous study showed that photobiomodulation (PBM) therapy and forskolin could reduce arecoline-induced fibrosis reactions via the cAMP pathway. The present study aimed to establish an animal model of areca nut extract (ANE)-induced OSMF and to evaluate the therapeutic potential of PBM and forskolin for ANE-induced OSMF.
Subjects and methods: The mice were divided into five groups. The buccal tissues were harvested for histomorphological analysis and immunoblotting.
Results: Our results showed that PBM significantly reduced the development of ANE-induced OSMF, quantified by changes in submucosal layer thickness and collagen deposition. Additionally, PBM could extensively reduce the protein expression of the fibrotic marker genes alpha-smooth muscle actin (α-SMA) and connective tissue growth factor (CTGF) in buccal submucous lesions. However, forskolin treatment significantly decreased the protein expression of fibrotic marker genes but slightly decreased the observed histomorphological changes.
Conclusions: We established an ANE-induced OSMF mouse model, which also provided a model for the development of a therapeutic treatment for OSMF. The anti-fibrotic effects of PBM and forskolin may be useful for clinical interventions.
Keywords: alpha-smooth muscle actin; anti-fibrosis; areca nut extract; cAMP; connective tissue growth factor; forskolin.
© 2020 The Authors. Oral Diseases published by John Wiley & Sons Ltd.
Figures




References
-
- Ahrabi, B. , Bahrami, M. , Moghadasali, R. , Zamanian‐Azodi, M. , Khoramgah, M. S. , Tabatabaei Mirakabad, F. S. , … Abbaszadeh, H. A. (2020). The effect of low‐power laser therapy on the TGF/beta signaling pathway in chronic kidney disease: A review. Journal of Lasers in Medical Sciences, 11(2), 220–225. 10.34172/jlms.2020.36 - DOI - PMC - PubMed
-
- Assis, L. , Moretti, A. I. , Abrahao, T. B. , de Souza, H. P. , Hamblin, M. R. , & Parizotto, N. A. (2013). Low‐level laser therapy (808 nm) contributes to muscle regeneration and prevents fibrosis in rat tibialis anterior muscle after cryolesion. Lasers in Medical Science, 28(3), 947–955. 10.1007/s10103-012-1183-3 - DOI - PMC - PubMed
-
- Chang, M. C. , Wu, H. L. , Lee, J. J. , Lee, P. H. , Chang, H. H. , Hahn, L. J. , … Jeng, J. H. (2004). The induction of prostaglandin E2 production, interleukin‐6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. Journal of Biological Chemistry, 279(49), 50676–50683. 10.1074/jbc.M404465200 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous